Journal of Nanobiotechnology,
Год журнала:
2022,
Номер
20(1)
Опубликована: Июнь 14, 2022
Abstract
The
tumor
microenvironment
(TME)
plays
a
key
role
in
cancer
development
and
emergence
of
drug
resistance.
TME
modulation
has
recently
garnered
attention
as
potential
approach
for
reprogramming
the
resensitizing
resistant
neoplastic
niches
to
existing
therapies
such
immunotherapy
or
chemotherapy.
Nano-based
solutions
have
important
advantages
over
traditional
platform
can
be
specifically
targeted
delivered
desired
sites.
This
review
explores
novel
nano-based
approaches
aimed
at
targeting
aberrant
components
macrophages,
fibroblasts,
vasculature,
hypoxia
ROS
pathways.
We
also
discuss
how
nanoplatforms
combined
with
anti-tumor
regimens
radiotherapy,
immunotherapy,
phototherapy
chemotherapy
enhance
clinical
outcomes
solid
tumors.
Frontiers in Immunology,
Год журнала:
2022,
Номер
13
Опубликована: Июнь 30, 2022
Different
stimuli
can
polarize
macrophages
into
two
basic
types,
M1
and
M2.
Tumor-associated
(TAMs)
in
the
tumor
microenvironment
(TME)
are
composed
of
heterogeneous
subpopulations,
which
include
anti-tumor
M2
pro-tumor
phenotypes.
TAMs
predominantly
play
a
M2-like
tumor-promoting
role
TME
regulate
various
malignant
effects,
such
as
angiogenesis,
immune
suppression,
metastasis;
hence,
have
emerged
hot
topic
research
cancer
therapy.
This
review
focuses
on
three
main
aspects
TAMs.
First,
we
summarize
macrophage
polarization
along
with
effects
TME.
Second,
recent
advances
challenges
treatment
checkpoint
blockade
CAR-T
cell
therapy
emphasized.
Finally,
factors,
signaling
pathways,
associated
TAM
potential
strategies
for
targeting
repolarization
to
pro-inflammatory
phenotype
discussed.
Journal of Experimental & Clinical Cancer Research,
Год журнала:
2022,
Номер
41(1)
Опубликована: Фев. 19, 2022
Abstract
Cancer
immunotherapy
has
emerged
as
a
novel
cancer
treatment,
although
recent
trials
have
produced
suboptimal
outcomes,
with
durable
responses
seen
only
in
small
number
of
patients.
The
tumor
microenvironment
(TME)
been
shown
to
be
responsible
for
immune
escape
and
therapy
failure.
vital
component
the
TME
is
tumor-associated
macrophages
(TAMs),
which
are
usually
associated
poor
prognosis
drug
resistance,
including
immunotherapies,
promising
targets
immunotherapy.
Recently,
nanoparticles,
because
their
unique
physicochemical
characteristics,
crucial
translational
moieties
tackling
tumor-promoting
TAMs
that
amplify
sensitize
tumors
immunotherapies
safe
effective
manner.
In
this
review,
we
mainly
described
current
potential
nanomaterial-based
therapeutic
strategies
target
TAMs,
restricting
survival,
inhibiting
recruitment
functionally
repolarizing
tumor-supportive
antitumor
type.
understanding
origin
polarization
role
progression
prognostic
significance
was
also
discussed
review.
We
highlighted
evolution
chimeric
antigen
receptor
(CAR)-macrophage
cell
therapy.
npj Precision Oncology,
Год журнала:
2024,
Номер
8(1)
Опубликована: Фев. 10, 2024
Abstract
Tumor
drug
resistance
emerges
from
the
interaction
of
two
critical
factors:
tumor
cellular
heterogeneity
and
immunosuppressive
nature
microenvironment
(TME).
Tumor-associated
macrophages
(TAMs)
constitute
essential
components
TME.
M2-like
TAMs
are
in
facilitating
metastasis
as
well
augmenting
tumors.
This
review
encapsulates
mechanisms
that
use
to
promote
resistance.
We
also
describe
emerging
therapeutic
strategies
currently
targeting
combination
with
other
antitumor
drugs,
some
still
undergoing
clinical
trial
evaluation.
Furthermore,
we
summarize
analyze
various
existing
approaches
for
developing
novel
drugs
target
overcome
resistance,
highlighting
how
can
effectively
stop
growth,
metastasis,
Abstract
Several
mechanisms
and
cell
types
are
involved
in
the
regulation
of
immune
response.
These
include
mostly
regulatory
T
cells
(Tregs),
macrophages
(Mregs),
myeloid
suppressor
(MDSCs)
other
such
as
tolerogenic
dendritic
(tolDCs),
B
(Bregs),
mesenchymal
stem
(MSCs).
cells,
known
for
their
ability
to
suppress
responses,
can
also
anti-tumor
The
infiltration
many
into
tumor
tissues
is
therefore
associated
with
a
poor
prognosis.
There
growing
evidence
that
elimination
Tregs
enhances
responses.
However,
systemic
depletion
Treg
simultaneously
cause
deleterious
autoimmunity.
Furthermore,
since
characterized
by
high
level
expression
checkpoints,
it
expected
checkpoint
inhibitors
perform
part
function
blocking
these
molecules
enhancing
This
indicates
immunotherapy
does
not
only
act
activating
specific
effector
but
directly
or
indirectly
attenuate
suppressive
activity
tissues.
review
aims
draw
together
our
current
knowledge
about
effect
on
various
how
effects
may
be
beneficial
response
immunotherapy.
Advanced Materials,
Год журнала:
2022,
Номер
34(9)
Опубликована: Янв. 12, 2022
The
protumoral
and
immunosuppressive
tumor
microenvironments
greatly
limit
the
antitumor
immune
responses
of
nanoparticles
for
cancer
immunotherapy.
Here,
intrinsic
immunomodulatory
effects
orchestrated
their
ability
to
simultaneously
trigger
antigen
release,
thereby
reversing
immunosuppression
achieving
potent
immunity
augmented
therapy,
are
explored.
By
optimizing
both
composition
morphology,
a
facile
strategy
is
proposed
construct
yolk-shell
nanohybrids
(Fe3
O4
@C/MnO2
-PGEA,
FCMP).
FCMP
utilized
reprogram
macrophages
M1
phenotype
induce
maturation
dendritic
cells.
In
addition,
chemical,
magnetic,
optical
properties
contribute
amplified
immunogenic
cell
death
induced
by
multiaugmented
chemodynamic
therapy
(CDT)
synergistic
treatment.
Taking
advantage
unique
structure,
accurate
T1
-T2
dual-mode
magnetic
resonance
imaging
can
be
realized
CDT
maximized
through
sufficient
exposure
Fe3
core
MnO2
shell.
Potent
found
substantially
inhibit
growth
primary
distant
tumors.
Furthermore,
extended
synthesis
other
with
tailored
properties.
This
work
establishes
novel
fabrication
multifunctional
nanoplatforms
structure
effective
immunomodulation-enhanced
immunity.
Advanced Materials,
Год журнала:
2023,
Номер
35(31)
Опубликована: Июнь 7, 2023
Photodynamic
therapy
(PDT)
has
achieved
great
success
in
cancer
treatment.
Despite
its
promise,
the
efficacy
of
photodynamic
immunotherapy
can
be
limited
by
hypoxia
solid
tumors
which
is
closely
related
to
abnormal
tumor
vasculature.
These
vasculatures
are
a
hallmark
most
and
facilitate
immune
evasion.
Therefore,
vascular
normalization
developed
as
promising
strategy
overcome
hypoxia,
resulting
improved
therapy.
Here,
NIR-II
bio-degradable
pseudo-conjugate
polymer
(PSP)-based
designed
deliver
agent,
i.e.,
regorafenib
(Reg)
nanoparticles
(NP-PDT@Reg).
NP-PDT@Reg
under
808
nm
laser
irradiation
(NP-PDT@Reg
+
L)
efficiently
release
Reg
improve
via
normalization,
making
more
oxygen
enter
tumors.
Moreover,
L
further
result
generation
reactive
species
(ROS)
eradicate
cells
while
inducing
immunogenic
cell
death
(ICD)
activate
anti-tumor
responses.
In
addition,
reprogram
TAM
from
pro-tumor
M2
phenotype
tumor-killing
M1
well,
thereby
reversing
immunosuppressive
microenvironment.
Taken
together,
current
study
provides
an
innovative
perspective
on
development
novel
nanomaterials
limitations
immunotherapy.
Expert Opinion on Drug Delivery,
Год журнала:
2023,
Номер
20(7), С. 937 - 954
Опубликована: Июнь 9, 2023
During
the
last
decades,
ever-increasing
proportion
of
patients
with
cancer
has
been
led
to
serious
concerns
worldwide.
Therefore,
development
and
use
novel
pharmaceuticals,
like
nanoparticles
(NPs)-based
drug
delivery
systems
(DDSs),
can
be
potentially
effective
in
therapy.Poly
lactic-co-glycolic
acid
(PLGA)
NPs,
as
a
kind
bioavailable,
biocompatible,
biodegradable
polymers,
have
approved
by
Food
Drug
Administration
(FDA)
for
some
biomedical
pharmaceutical
applications.
PLGA
is
comprised
lactic
(LA)
glycolic
(GA)
their
ratio
could
controlled
during
various
syntheses
preparation
approaches.
LA/GA
determines
stability
degradation
time
PLGA;
lower
content
GA
results
fast
degradation.
There
are
several
approaches
preparing
NPs
that
affect
aspects,
such
size,
solubility,
stability,
loading,
pharmacokinetics,
pharmacodynamics,
so
on.These
indicated
sustained
release
site
passive
active
(via
surface
modification)
DDSs.
This
review
aims
provide
an
overview
approach
physicochemical
mechanism
cellular
fate,
DDSs
efficient
therapy,
status
industry
nanomedicine.
Advanced Energy Materials,
Год журнала:
2023,
Номер
13(19)
Опубликована: Апрель 5, 2023
Abstract
Biosynthesis
methods
are
considered
to
be
a
promising
technology
for
engineering
new
carbon‐based
materials
or
redesigning
the
existing
ones
specific
purposes
with
aid
of
synthetic
biology.
Lots
biosynthetic
processes
including
metabolism,
fermentation,
biological
mineralization,
and
gene
editing
have
been
adopted
prepare
novel
exceptional
properties
that
cannot
realized
by
traditional
chemical
methods,
because
microbes
evolved
possess
special
abilities
modulate
components/structure
materials.
In
this
review,
recent
development
on
prepared
via
different
biosynthesis
various
microbe
factories
(such
as
bacteria,
yeasts,
fungus,
viruses,
proteins)
systematically
reviewed.
The
types
biotechniques
corresponding
mechanisms
synthesis
outlined.
This
review
also
focuses
structural
design
compositional
nanostructures
(e.g.,
metals,
semiconductors,
metal
oxides,
sulfides,
phosphates,
Mxenes)
derived
from
biotechnology
their
applications
in
electrochemical
energy
storage
devices.
Moreover,
relationship
architecture–composition–electrochemical
behavior
performance
enhancement
mechanism
is
deeply
discussed
analyzed.
Finally,
perspectives
challenges
carbons
proposed
may
pave
avenue
rational
advanced
low‐carbon
economy.